Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In Situ/spatial) services. The company also provides whole genome, whole exome, transcriptome, epigenome, and metagenome sequencing services; standard sequencing, identification, fragment, customized sequencing, and human ID services; expression, genome, and epigenome microarray; proteomics olink; gene synthesis; DNA and RNA oligo synthesis, and peptide synthesis; and CRISPR knock-in/out, GEM, and mass production services. Macrogen, Inc. was founded in 1997 and is based in Seoul, South Korea.
तुलना करने के लिए मीट्रिक्स | 038290 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध038290पीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | 91.6x | 9.1x | −0.4x | |
PEG अनुपात | 0.74 | 0.04 | 0.00 | |
क़ीमत/बुक | 1.2x | 2.3x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 1.0x | 2.1x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | 45.8% | 44.3% | 46.2% | |
उचित मूल्य अपसाइड | अनलॉक करें | −26.2% | 7.2% | अनलॉक करें |